American Association for the Study of Liver Diseases--53rd Annual Meeting. 1-5 November 2002, Boston, MA, USA
Levitsky, J.
IDrugs the investigational drugs journal 6(1): 30-33
2003
ISSN/ISBN: 1369-7056 PMID: 12838972 Document Number: 554629
Document emailed within 1 workday
Related Documents
Yu, E.Y. 2011: Highlights in prostate cancer from the 2011 American Urological Association Annual Meeting and the 2011 American Society of Clinical Oncology Annual Meeting Clinical Advances in Hematology and Oncology: H&o 9(8 Suppl. 21): 1-241979: Sociedad de Bioquímica de Chile, 3d annual meeting. Pan-American Association of Biochemical Societies, 2d southern regional meeting. Abstracts Archivos de Biologia Y Medicina Experimentales 12(2): 233-289
Mazucco, R. 2001: American Urological Association - 96th Annual Meeting. 2-7 June 2001, Anaheim, CA, USA IDrugs: the investigational drugs journal 4(8): 892-895
Oshika, T.; Amano, S.; Nishida, K.; Saika, S.; Fukushima, A. 2014: "Another stimulating meeting on basic and clinical corneal research," 19th Annual Meeting of the Kyoto Cornea Club, November 29-30, 2013 Cornea 33 Suppl. 11: S1-S2
Williams, L.; Mazucco, R. 2002: American Association for Cancer Research - 93rd Annual Meeting. Signal transduction. 6-10 April 2002, San Francisco, CA, USA IDrugs: the investigational drugs journal 5(5): 412-415
Phillips, T.; Collins, T.; Davies, J. 2005: American Association for Cancer Research--96th Annual Meeting. Targeting the cell cycle and HDAC inhibitors IDrugs: the investigational drugs journal 8(6): 450-453
Anonymous 1965: American Association of Pathologists and Bacteriologists. Scientific proceedings, 62nd annual meeting, Philadelphia, Pa., March 1965 Amer. J. Pathol, 46: la-45a
Denny, W.A. 2002: American Association for Cancer Research - 93rd Annual Meeting. Investigational kinase inhibitors. 6-10 April 2002, San Francisco, CA, USA IDrugs: the investigational drugs journal 5(5): 416-421
1988: Mexican Group for the Study of the Blood. 28th annual meeting. Puebla, Pue. (Mexico), 7-11 November 1987. Abstracts Sangre 33(1): 65-89
Anonymous 1970: Eighth annual meeting, Brno, November 4--6, 1969; abstracts of communications Folia Microbiologica 5(3): 196-241
Dalziel, C.; Veryard, C. 2007: American Chemical Society--234th National Meeting. Therapeutics for neurological indications. 19-23 August 2007, Boston, MA, USA IDrugs: the investigational drugs journal 10(10): 676-677
Aharony, L. 2004: American Geriatrics Society, Annual Scientific Meeting, Baltimore May 2003 Harefuah 143(2): 149-151
McGowran, M. 2001: American Society of Gene Therapy - Fourth Annual Meeting. 30 May-3 June 2001, Seattle, WA, USA IDrugs: the investigational drugs journal 4(8): 896-900
Walker, K.; Kibble, A.; Shumoogam, J. 2007: American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 1 IDrugs: the investigational drugs journal 10(8): 513-516
Rotella, D.P. 2004: American Chemical Society--227th annual meeting. Diabetes. 28 March - 1 April 2004, Anaheim, CA, USA IDrugs: the investigational drugs journal 7(5): 428-429
Chen, R. 2012: Highlights in lymphoma from the 2012 European Hematology Association Annual Meeting Clinical Advances in Hematology and Oncology: H&o 10(9 Suppl. 16): 1-24
Morse, M.A. 2001: American Society of Clinical Oncology - 37th Annual Meeting. Small molecule tyrosine kinase inhibitors. 12-15 May 2001, San Francisco, CA, USA IDrugs: the investigational drugs journal 4(8): 857-859
McKinnon, C. 1998: American Society of Clinical Oncology--34th Annual Meeting. Treatments for prostate cancer and new molecular targets. 16-19 May 1998, Los Angeles, California, USA IDrugs: the investigational drugs journal 1(2): 163-167
1988: Federation of American Societies for Experimental Biology. 72nd annual meeting. Las Vegas, Nevada, May 1-5, 1988. Abstracts of papers 3786-7553 Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 2(5): A947-1596
Chan, D.; Cleverley, J. 2006: American Society of Clinical Oncology--42nd annual meeting. Current approaches to lung cancer therapy. 2-6 June 2006, Atlanta, GA, USA IDrugs: the investigational drugs journal 9(8): 523-525